{
    "code": "02022380",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022380",
    "time": "2019-03-22 04:15:41",
    "許可證字號": "衛署藥輸字第022380號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/10\/19",
    "註銷理由": "自請註銷",
    "有效日期": "108\/01\/19",
    "發證日期": "88\/01\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202238002",
    "中文品名": "循能素注射液",
    "英文品名": "TRENTAL INJECTION",
    "適應症": "末梢血管循環障礙",
    "劑型": "270注射劑",
    "包裝": "盒裝 小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "PENTOXIFYLLINE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F470108000  SANOFI-AVENTIS DEUTSCHLAND GMBH",
        "製造廠廠址": "BRUNINGSTRASSE 50, D-65926 FRANKFURT (MAIN), GERMANY",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412002100",
            "成分名稱": "PENTOXIFYLLINE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Trental Inj LPI_C_CCDS V6 & 7_TFDA app 2015.12.11-104-12-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022380&Seq=005&Type=9"
        },
        {
            "title": "Trental Inj_artwork-104-09-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022380&Seq=001&Type=8"
        }
    ]
}